Notably, tumor cell lines with KRT81 knockdown demonstrated a diminished capacity to inhibit CD8 + T cells, suggesting that elevated levels of KRT81 promote an immunosuppressive microenvironment in TNBC. Here, CD8A is linked to neoplasm.